(Q35207161)

7 August 2017

title

Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas (English)

1 reference

single-nucleotide polymorphism

7 August 2017

0 references

1 reference

11

1 reference

7 August 2017

3

Agnes Bankfalvi

0 references

author name string

Christoph Bergmann

1

1 reference

7 August 2017

Hagen S Bachmann

2

1 reference

7 August 2017

Ramin Lotfi

4

1 reference

7 August 2017

Carolin Pütter

5

1 reference

7 August 2017

Clarissa A Wild

6

1 reference

7 August 2017

Patrick J Schuler

7

1 reference

7 August 2017

Jens Greve

8

1 reference

7 August 2017

Thomas K Hoffmann

9

1 reference

7 August 2017

Stephan Lang

10

1 reference

7 August 2017

Götz F Lehnerdt

12

1 reference

7 August 2017

publication date

21 August 2011

1 reference

Journal of Translational Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

9

1 reference

7 August 2017

page(s)

139

1 reference

Creative Commons Attribution 2.0 Generic

7 August 2017

copyright license

start time

21 August 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Impact of Toll-like receptor 4 polymorphisms on risk of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

In vivo depletion of T lymphocyte-specific transcription factors by RNA interference.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Targeting Toll-like receptors: emerging therapeutics?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

HMGB1 and RAGE in inflammation and cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Toll-like receptors and cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

The anticancer immune response: indispensable for therapeutic success?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Functional consequences of toll-like receptor 4 polymorphisms

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Case-control study of human papillomavirus and oropharyngeal cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Pathogen recognition and innate immunity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Lipopolysaccharide signaling in endothelial cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Tobacco and cancer: recent epidemiological evidence

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

13 July 2018

Inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Inflammation and cancer: back to Virchow?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Impact of Toll-like receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in cervical cancer susceptibility in North Indian women.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Tobacco abuse relates to significantly reduced survival of patients with oropharyngeal carcinomas

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170603

26 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-9-139

Effect of a novel anatomically shaped endotracheal tube on intubation-related injury

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1479-5876-9-139

Toll-like Receptor 4 Polymorphisms and Atherogenesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1479-5876-9-139

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21854645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Toll-like Receptors in Regulatory T Cells of Patients With Head and Neck Cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21854645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21854645

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1479-5876-9-139

1 reference

7 August 2017

1 reference

7 August 2017

1 reference